17
09, 2015
15
09, 2015
15
09, 2015
15
09, 2015
Valentina Guarneri et al., Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer. The Oncologist
Diatech Pharmacogenetics2017-08-08T09:48:41+02:00
15
09, 2015
10
09, 2015
Diatech Pharmacogenetics è partner della CNA per il progetto FUTUREMAKERS
Diatech Pharmacogenetics2017-08-21T15:37:52+02:00
9
09, 2015
Nozze d’argento per Myriapod® – Diatech Pharmacogenetics
Diatech Pharmacogenetics2017-08-29T09:08:08+02:00
21
08, 2015
Giornata nazionale di lancio dei bandi 2016-17 Horizon 2020
Diatech Pharmacogenetics2017-08-21T15:42:28+02:00
8
08, 2015
1
08, 2015